Clinical Trials Directory

Trials / Unknown

UnknownNCT01634204

Efficacy of a Web-based Weight Loss Program

Is the Support of a Web-based Weight Loss Program Effective in Supporting Self-initiated Weight Loss and Lifestyle Changes?

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
84 (actual)
Sponsor
Charite University, Berlin, Germany · Academic / Other
Sex
All
Age
30 Years – 65 Years
Healthy volunteers
Accepted

Summary

Since overweight and obesity, a risk factor for various diseases, is a prevalent problem in the modern society, it is important to search for new strategies to counteract this. In contrast to in person support, the internet provides a low cost opportunity, which is able to reach a large part of the population. Therefore a web-based weight loss program may be an adequate mean for many people. Now it is hypothesised that a web-based weight loss program is able to support a reduction of body weight and weight-related cardiovascular risk factors effectively and to promote a healthier lifestyle. It is expected that program use, compared to a control group, results in greater reductions in body weight and cardiovascular risk.

Conditions

Interventions

TypeNameDescription
OTHERKiloCoachStudy participants in this arm will use the program to record nutrition and physical activity on at least 4 days per week within the first and ad libitum within the second 3 months of the intervention period. Study visits will be conducted at baseline as well as after 1, 3 and 6 months. After 12 months a follow up visit will be conducted.
OTHERControlStudy subjects try to reduce their body weight on their own. They are free to exercise and/or change nutritional habits. Not allowed is taking part in any structured weight loss program. Study visits will be conducted at baseline as well as after 1,3 and 6 months. A follow up visit will be conducted after 12 months.

Timeline

Start date
2011-09-01
Primary completion
2012-10-01
Completion
2013-07-01
First posted
2012-07-06
Last updated
2012-07-06

Locations

3 sites across 2 countries: Austria, Germany

Source: ClinicalTrials.gov record NCT01634204. Inclusion in this directory is not an endorsement.